Kolexia
Salvo Francesco Biologie médicale
Salvo Francesco
Biologie médicale
Hôpital Pellegrin
Bordeaux, France
286 Activités
668 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Effets secondaires indésirables des médicaments COVID-19 Diabète de type 2 Diabète Tumeurs colorectales Myocardite Tumeurs du poumon Hypoglycémie Carcinome pulmonaire non à petites cellules

Collaborateurs

Voir plus
Pariente Antoine
Pariente Antoine
Hôpital Pellegrin, Bordeaux, France
Micallef-Roll Joelle
Micallef-Roll Joelle
Hôpital La Timone, Marseille, France
Bezin Julien
Bezin Julien
Hôpital Pellegrin, Bordeaux, France
Letinier Louis
Letinier Louis
Synapse Medecine, Bordeaux, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Resective epilepsy surgery and its impact on depression in adults: a systematic review, meta-analysis, and implications for future research.
Journal of neurology, neurosurgery, and psychiatry   05 mars 2024
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real-life settings: A nationwide population-based cohort study.
Mycoses   20 novembre 2023
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France.
Drug safety   05 novembre 2023
Analgesic switching in chronic users of dextropropoxyphene in France.
Fundamental & clinical pharmacology   21 octobre 2023
Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase.
Pharmaceuticals (Basel, Switzerland)   05 octobre 2023
Safety of antituberculosis agents used for multidrug-resistant tuberculosis among patients attending the Jamot Hospital of Yaounde, Cameroon.
International journal of mycobacteriology   27 septembre 2023
Dual Orexin Receptor Antagonists and Suicide Risk: Findings From the WHO Spontaneous Reporting Database.
The Journal of clinical psychiatry   27 septembre 2023
Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer.
Targeted oncology   08 septembre 2023
Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control study.
British journal of haematology   24 juillet 2023
PROSIT: Development, Validation and Impact of an Automatic Identification of Co-Prescription at Risk of Interactions in the Hospital Information System. The PRoSIT System.
Essai Clinique (Synapse bv)   18 juillet 2023